Allergan Inc. (AGN) reported that its fourth-quarter net earnings attributable to stockholders were $221.5 million or $0.72 per share, compared to $146.6 million or $0.48 per share in the year ago quarter.
Non-GAAP net earnings attributable to stockholders were $238.1 million or $0.78 per share, compared to $229.8 million or $0.76 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.77 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $1.22 billion, compared to $1.06 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $1.16 billion for the quarter.
Allergan also announced that its Board of Directors has declared a fourth quarter dividend of $0.05 per share, payable on March 12, 2010 to stockholders of record on February 19, 2010.
For the first quarter of 2010, Allergan expects total product net sales between $1.060 billion and $1.100 billion. Non-GAAP earnings per share attributable to stockholders are expected to be between $0.57 and $0.59. Analysts expect the company to report earnings of $0.68 per share for the quarter.
For the full year of 2010, Allergan expects total product net sales to be between $4.550 billion and $4.750 billion. Non-GAAP earnings per share attributable to stockholders are expected to be between $3.09 and $3.15. Analysts expect the company to report earnings of $3.15 per share for fiscal 2010.
For comments and feedback: editorial@rttnews.com